Jakavi 5 mg tablets clinical trials

Combination Therapy with Interferon-Alpha2a and Ruxolitinib in Newly Diagnosed Patients with Polycythemia Vera. A Danish Safety and Efficacy Study.

This study is looking at two medicines, Peginterferon alfa-2a and Ruxolitinib (Jakavi), together for people newly diagnosed with a blood condition called Polycythemia Vera. Researchers want to see how safe this combination is and how well it works.